English
简体中文
Total: £ 56.28
Published Date: 2025-11-06 | Pages: 159 | Tables: 161 | Pharma & Healthcare
The global Anti-Inflammatory and Analgesic Gel market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Anti-Inflammatory and Analgesic Gel leading manufacturers including Novartis, Pfizer, GlaxoSmithKline, Johnson & Johnson, Sanofi, Sun Pharmaceutical Industries, AdvaCare Pharma, Topical BioMedics, Health & Beyond, Troy Healthcare, etc., dominate supply; the top five capture approximately % of global revenue, with Novartis leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Anti-Inflammatory and Analgesic Gel market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Novartis
Pfizer
GlaxoSmithKline
Johnson & Johnson
Sanofi
Sun Pharmaceutical Industries
AdvaCare Pharma
Topical BioMedics
Health & Beyond
Troy Healthcare
Glydex Pharmaceutical
Microwin
Segment by Type
Prescription Pain Relief Gel
Over-the-Counter Pain Relief Gel
Segment by Application
Hospital
Home Care
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Anti-Inflammatory and Analgesic Gel study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Anti-Inflammatory and Analgesic Gel: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Anti-Inflammatory and Analgesic Gel Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Prescription Pain Relief Gel
1.2.3 Over-the-Counter Pain Relief Gel
1.3 Market Segmentation by Application
1.3.1 Global Anti-Inflammatory and Analgesic Gel Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home Care
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-Inflammatory and Analgesic Gel Revenue Estimates and Forecasts 2020-2031
2.2 Global Anti-Inflammatory and Analgesic Gel Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Anti-Inflammatory and Analgesic Gel Sales Estimates and Forecasts 2020-2031
2.4 Global Anti-Inflammatory and Analgesic Gel Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Anti-Inflammatory and Analgesic Gel Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Anti-Inflammatory and Analgesic Gel Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Prescription Pain Relief Gel Market Size by Manufacturers
3.5.2 Over-the-Counter Pain Relief Gel Market Size by Manufacturers
3.6 Global Anti-Inflammatory and Analgesic Gel Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Anti-Inflammatory and Analgesic Gel Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Anti-Inflammatory and Analgesic Gel Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Anti-Inflammatory and Analgesic Gel Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Anti-Inflammatory and Analgesic Gel Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Anti-Inflammatory and Analgesic Gel Sales and Revenue by Type (2020-2031)
6.4 North America Anti-Inflammatory and Analgesic Gel Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Anti-Inflammatory and Analgesic Gel Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Anti-Inflammatory and Analgesic Gel Sales and Revenue by Type (2020-2031)
7.4 Europe Anti-Inflammatory and Analgesic Gel Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Anti-Inflammatory and Analgesic Gel Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Anti-Inflammatory and Analgesic Gel Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Anti-Inflammatory and Analgesic Gel Sales and Revenue by Type (2020-2031)
9.4 Central and South America Anti-Inflammatory and Analgesic Gel Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Anti-Inflammatory and Analgesic Gel Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Anti-Inflammatory and Analgesic Gel Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview
11.1.3 Novartis Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.1.4 Novartis Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Novartis Anti-Inflammatory and Analgesic Gel Sales by Product in 2024
11.1.6 Novartis Anti-Inflammatory and Analgesic Gel Sales by Application in 2024
11.1.7 Novartis Anti-Inflammatory and Analgesic Gel Sales by Geographic Area in 2024
11.1.8 Novartis Anti-Inflammatory and Analgesic Gel SWOT Analysis
11.1.9 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.2.4 Pfizer Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Pfizer Anti-Inflammatory and Analgesic Gel Sales by Product in 2024
11.2.6 Pfizer Anti-Inflammatory and Analgesic Gel Sales by Application in 2024
11.2.7 Pfizer Anti-Inflammatory and Analgesic Gel Sales by Geographic Area in 2024
11.2.8 Pfizer Anti-Inflammatory and Analgesic Gel SWOT Analysis
11.2.9 Pfizer Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.3.4 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Sales by Product in 2024
11.3.6 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Sales by Application in 2024
11.3.7 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel Sales by Geographic Area in 2024
11.3.8 GlaxoSmithKline Anti-Inflammatory and Analgesic Gel SWOT Analysis
11.3.9 GlaxoSmithKline Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.4.4 Johnson & Johnson Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Johnson & Johnson Anti-Inflammatory and Analgesic Gel Sales by Product in 2024
11.4.6 Johnson & Johnson Anti-Inflammatory and Analgesic Gel Sales by Application in 2024
11.4.7 Johnson & Johnson Anti-Inflammatory and Analgesic Gel Sales by Geographic Area in 2024
11.4.8 Johnson & Johnson Anti-Inflammatory and Analgesic Gel SWOT Analysis
11.4.9 Johnson & Johnson Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.5.4 Sanofi Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sanofi Anti-Inflammatory and Analgesic Gel Sales by Product in 2024
11.5.6 Sanofi Anti-Inflammatory and Analgesic Gel Sales by Application in 2024
11.5.7 Sanofi Anti-Inflammatory and Analgesic Gel Sales by Geographic Area in 2024
11.5.8 Sanofi Anti-Inflammatory and Analgesic Gel SWOT Analysis
11.5.9 Sanofi Recent Developments
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Corporation Information
11.6.2 Sun Pharmaceutical Industries Business Overview
11.6.3 Sun Pharmaceutical Industries Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.6.4 Sun Pharmaceutical Industries Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sun Pharmaceutical Industries Recent Developments
11.7 AdvaCare Pharma
11.7.1 AdvaCare Pharma Corporation Information
11.7.2 AdvaCare Pharma Business Overview
11.7.3 AdvaCare Pharma Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.7.4 AdvaCare Pharma Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 AdvaCare Pharma Recent Developments
11.8 Topical BioMedics
11.8.1 Topical BioMedics Corporation Information
11.8.2 Topical BioMedics Business Overview
11.8.3 Topical BioMedics Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.8.4 Topical BioMedics Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Topical BioMedics Recent Developments
11.9 Health & Beyond
11.9.1 Health & Beyond Corporation Information
11.9.2 Health & Beyond Business Overview
11.9.3 Health & Beyond Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.9.4 Health & Beyond Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Health & Beyond Recent Developments
11.10 Troy Healthcare
11.10.1 Troy Healthcare Corporation Information
11.10.2 Troy Healthcare Business Overview
11.10.3 Troy Healthcare Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.10.4 Troy Healthcare Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Troy Healthcare Recent Developments
11.11 Glydex Pharmaceutical
11.11.1 Glydex Pharmaceutical Corporation Information
11.11.2 Glydex Pharmaceutical Business Overview
11.11.3 Glydex Pharmaceutical Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.11.4 Glydex Pharmaceutical Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Glydex Pharmaceutical Recent Developments
11.12 Microwin
11.12.1 Microwin Corporation Information
11.12.2 Microwin Business Overview
11.12.3 Microwin Anti-Inflammatory and Analgesic Gel Product Models, Descriptions and Specifications
11.12.4 Microwin Anti-Inflammatory and Analgesic Gel Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Microwin Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Anti-Inflammatory and Analgesic Gel Industry Chain
12.2 Anti-Inflammatory and Analgesic Gel Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Anti-Inflammatory and Analgesic Gel Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Anti-Inflammatory and Analgesic Gel Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Anti-Inflammatory and Analgesic Gel Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Anti-Inflammatory and Analgesic Gel Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Anti-Inflammatory and Analgesic Gel Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Anti-Inflammatory and Analgesic Gel Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Anti-Inflammatory and Analgesic Gel Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Anti-Inflammatory and Analgesic Gel Sales by Region (2020-2025) & (K Units)
Table 8. Global Anti-Inflammatory and Analgesic Gel Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Anti-Inflammatory and Analgesic Gel Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Anti-Inflammatory and Analgesic Gel Sales Share by Manufacturers (2020-2025)
Table 12. Global Anti-Inflammatory and Analgesic Gel Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Anti-Inflammatory and Analgesic Gel by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Inflammatory and Analgesic Gel as of 2024)
Table 16. Global Anti-Inflammatory and Analgesic Gel Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Anti-Inflammatory and Analgesic Gel Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Anti-Inflammatory and Analgesic Gel Manufacturing Base and Headquarters
Table 19. Global Anti-Inflammatory and Analgesic Gel Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Anti-Inflammatory and Analgesic Gel Sales by Type (2020-2025) & (K Units)
Table 23. Global Anti-Inflammatory and Analgesic Gel Sales by Type (2026-2031) & (K Units)
Table 24. Global Anti-Inflammatory and Analgesic Gel Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Anti-Inflammatory and Analgesic Gel Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-Inflammatory and Analgesic Gel ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Anti-Inflammatory and Analgesic Gel Sales by Application (2020-2025) & (K Units)
Table 29. Global Anti-Inflammatory and Analgesic Gel Sales by Application (2026-2031) & (K Units)
Table 30. Anti-Inflammatory and Analgesic Gel High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Anti-Inflammatory and Analgesic Gel Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Anti-Inflammatory and Analgesic Gel Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Anti-Inflammatory and Analgesic Gel ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Anti-Inflammatory and Analgesic Gel Growth Accelerators and Market Barriers
Table 37. North America Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Anti-Inflammatory and Analgesic Gel Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Anti-Inflammatory and Analgesic Gel Growth Accelerators and Market Barriers
Table 40. Europe Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Anti-Inflammatory and Analgesic Gel Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Anti-Inflammatory and Analgesic Gel Growth Accelerators and Market Barriers
Table 45. Southeast Asia Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Anti-Inflammatory and Analgesic Gel Investment Opportunities and Key Challenges
Table 47. Central and South America Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Anti-Inflammatory and Analgesic Gel Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Novartis Corporation Information
Table 51. Novartis Description and Major Businesses
Table 52. Novartis Product Models, Descriptions and Specifications
Table 53. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Novartis Sales Value Proportion by Product in 2024
Table 55. Novartis Sales Value Proportion by Application in 2024
Table 56. Novartis Sales Value Proportion by Geographic Area in 2024
Table 57. Novartis Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 58. Novartis Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Major Businesses
Table 61. Pfizer Product Models, Descriptions and Specifications
Table 62. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Pfizer Sales Value Proportion by Product in 2024
Table 64. Pfizer Sales Value Proportion by Application in 2024
Table 65. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 66. Pfizer Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. GlaxoSmithKline Corporation Information
Table 69. GlaxoSmithKline Description and Major Businesses
Table 70. GlaxoSmithKline Product Models, Descriptions and Specifications
Table 71. GlaxoSmithKline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. GlaxoSmithKline Sales Value Proportion by Product in 2024
Table 73. GlaxoSmithKline Sales Value Proportion by Application in 2024
Table 74. GlaxoSmithKline Sales Value Proportion by Geographic Area in 2024
Table 75. GlaxoSmithKline Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 76. GlaxoSmithKline Recent Developments
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Major Businesses
Table 79. Johnson & Johnson Product Models, Descriptions and Specifications
Table 80. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 82. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 83. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 84. Johnson & Johnson Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 85. Johnson & Johnson Recent Developments
Table 86. Sanofi Corporation Information
Table 87. Sanofi Description and Major Businesses
Table 88. Sanofi Product Models, Descriptions and Specifications
Table 89. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sanofi Sales Value Proportion by Product in 2024
Table 91. Sanofi Sales Value Proportion by Application in 2024
Table 92. Sanofi Sales Value Proportion by Geographic Area in 2024
Table 93. Sanofi Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 94. Sanofi Recent Developments
Table 95. Sun Pharmaceutical Industries Corporation Information
Table 96. Sun Pharmaceutical Industries Description and Major Businesses
Table 97. Sun Pharmaceutical Industries Product Models, Descriptions and Specifications
Table 98. Sun Pharmaceutical Industries Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sun Pharmaceutical Industries Recent Developments
Table 100. AdvaCare Pharma Corporation Information
Table 101. AdvaCare Pharma Description and Major Businesses
Table 102. AdvaCare Pharma Product Models, Descriptions and Specifications
Table 103. AdvaCare Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. AdvaCare Pharma Recent Developments
Table 105. Topical BioMedics Corporation Information
Table 106. Topical BioMedics Description and Major Businesses
Table 107. Topical BioMedics Product Models, Descriptions and Specifications
Table 108. Topical BioMedics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Topical BioMedics Recent Developments
Table 110. Health & Beyond Corporation Information
Table 111. Health & Beyond Description and Major Businesses
Table 112. Health & Beyond Product Models, Descriptions and Specifications
Table 113. Health & Beyond Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Health & Beyond Recent Developments
Table 115. Troy Healthcare Corporation Information
Table 116. Troy Healthcare Description and Major Businesses
Table 117. Troy Healthcare Product Models, Descriptions and Specifications
Table 118. Troy Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Troy Healthcare Recent Developments
Table 120. Glydex Pharmaceutical Corporation Information
Table 121. Glydex Pharmaceutical Description and Major Businesses
Table 122. Glydex Pharmaceutical Product Models, Descriptions and Specifications
Table 123. Glydex Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Glydex Pharmaceutical Recent Developments
Table 125. Microwin Corporation Information
Table 126. Microwin Description and Major Businesses
Table 127. Microwin Product Models, Descriptions and Specifications
Table 128. Microwin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Microwin Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Inflammatory and Analgesic Gel Product Picture
Figure 2. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Prescription Pain Relief Gel Product Picture
Figure 4. Over-the-Counter Pain Relief Gel Product Picture
Figure 5. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Home Care
Figure 8. Other
Figure 9. Anti-Inflammatory and Analgesic Gel Report Years Considered
Figure 10. Global Anti-Inflammatory and Analgesic Gel Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 12. Global Anti-Inflammatory and Analgesic Gel Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Region (2020-2031)
Figure 14. Global Anti-Inflammatory and Analgesic Gel Sales (2020-2031) & (K Units)
Figure 15. Global Anti-Inflammatory and Analgesic Gel Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Volume Market Share in 2024
Figure 18. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Prescription Pain Relief Gel Revenue Market Share by Manufacturer in 2024
Figure 21. Over-the-Counter Pain Relief Gel Revenue Market Share by Manufacturer in 2024
Figure 22. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2020-2031)
Figure 23. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Type (2020-2031)
Figure 24. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Application (2020-2031)
Figure 25. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Application (2020-2031)
Figure 26. North America Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 27. North America Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 29. North America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 39. Europe Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 44. France Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 59. India Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 80. Anti-Inflammatory and Analgesic Gel Industry Chain Mapping
Figure 81. Regional Anti-Inflammatory and Analgesic Gel Manufacturing Base Distribution (%)
Figure 82. Global Anti-Inflammatory and Analgesic Gel Production Market Share by Region (2020-2031)
Figure 83. Anti-Inflammatory and Analgesic Gel Production Process
Figure 84. Regional Anti-Inflammatory and Analgesic Gel Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
